CC of 115 AAL-Derived Regions in Individual Participants
Participant | Classification (NACC diagnosis) | Amyloid | CC* |
---|---|---|---|
1 | MCI_LBD | Positive | 0.95 |
2 | Dementia_AD | Positive | 0.95 |
3 | Normal | Negative | 0.93 |
4 | MCI_LBD | Negative | 0.95 |
5 | Normal | Positive | 0.87 |
6 | Normal | Positive | 0.76 |
7 | MCI_CBD | Positive | 0.70 |
8 | Normal | Positive | 0.93 |
9 | MCI_IMPSUB | Negative | 0.85 |
10 | Normal | Positive | 0.85 |
11 | MCI_AD | Negative | 0.90 |
12 | Normal | Negative | 0.93 |
13 | MCI_LBD | Negative | 0.91 |
14 | MCI_CBD | Negative | 0.88 |
15 | Dementia_AD | Positive | 0.93 |
16 | Dementia_AD | Positive | 0.87 |
17 | MCI_LBD | Negative | 0.93 |
18 | MCI_AD | Positive | 0.84 |
19 | Normal | Negative | 0.95 |
20 | Normal | Negative | 0.94 |
↵* Median = 0.92 (interquartile range, 0.87–0.93).
NACC = National Alzheimer Coordinating Center; LBD = dementia with Lewy bodies; CBD = corticobasilar degeneration; IMPSUB = cognitive impairment due to substance abuse.